Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NCNO | STDN |
|---|---|---|
| Price | $19.28 | $13.01 |
| Change today | ▲ 3.21% | ▲ 3.91% |
| Market cap | $2.04B | $2.04B |
| Return, 3 months | +6.8% | – |
| Return, year to date | -24.8% | – |
| Return, 1 year | -26.0% | – |
| P/E (TTM) | 62.2 | -121.6 |
| P/B | 2.2 | -26.2 |
| P/E percentile vs own 5y | – | 42nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +10.0% | – |
| Net profit growth (YoY) | +129.4% | – |
| Gross margin | 60.6% | -144.4% |
| Operating margin | 0.6% | -287.6% |
| Net margin | 1.6% | -494.9% |
| Return on equity | – | – |
| Analyst target vs. price | +28.0% | +28.1% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 45 | 53 |
| 30-day volatility | 51.4% | 93.8% |
| Max drawdown, 1 year | -52.2% | -40.4% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
